Related Experiment Video
Updated: Aug 10, 2026

08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Towards implantable glucose sensors: a review
1Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque 87131.
Summary
Reliable, long-lasting implantable glucose sensors are crucial for developing advanced diabetes mellitus management devices. This review covers various sensor types, aiding future technological advancements.
Area of Science:
- Biomedical Engineering
- Medical Device Technology
- Diabetes Management
Background:
- Clinical diabetes mellitus treatment relies on mechanical devices, with closed-loop systems being superior to open-loop.
- Effective closed-loop systems necessitate dependable, durable glucose sensors.
- The development of advanced diabetes monitoring tools is hindered by the lack of ideal glucose sensors.
Purpose of the Study:
- To review the current status of implantable glucose sensors.
- To classify and discuss different types of glucose sensors.
- To present the relative merits and experimental findings of various sensor technologies.
Main Methods:
- Classification of glucose sensors into categories: enzyme-catalyzed electrodes, metal-catalyzed sensors, affinity sensors, and coated wire sensors.
- Review of existing literature on implantable glucose sensor technologies.
- Summarization of experimental results from both in vitro and in vivo studies.
Main Results:
- Different glucose sensor types exhibit varying advantages and disadvantages.
- Experimental data from in vitro and in vivo studies provide insights into sensor performance.
- The review highlights the critical role of sensor reliability and longevity.
Conclusions:
- Advancements in closed-loop diabetes management systems are contingent upon the development of superior implantable glucose sensors.
- Understanding the characteristics and performance of different sensor types is essential for future innovation.
- Further research and development are needed to create reliable, long-lasting glucose sensors for clinical use.
Related Concept Videos
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...

